STOCK TITAN

Kiora Pharmaceuticals to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Kiora Pharmaceuticals (NASDAQ: KPRX) will be presenting at two upcoming investor conferences, The 23rd Annual Needham Virtual Healthcare Conference on April 11th and The Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18th. Investors can access the live presentations on Kiora's website and replay them for 90 days.
Positive
  • None.
Negative
  • None.

Encinitas, California--(Newsfile Corp. - April 5, 2024) - Kiora Pharmaceuticals (NASDAQ: KPRX) invites investors to view the Company's online presentations from two upcoming investor conferences.

Kiora will present at The 23rd Annual Needham Virtual Healthcare Conference on April 11th, at 10:15 am EDT. The Company will also present at The Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference, on April 18th at 2:30 pm EDT.

Both presentations can be accessed live from the homepage of the investor relations section on Kiora's website (ir.kiorapharma.com) and will be available for replay for 90 days on the investor relations "events" page.

About Kiora Pharmaceuticals

Kiora Pharmaceuticals is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. KIO-301 is being developed for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

In addition to news releases and SEC filings, we expect to post information on our website (www.kiorapharma.com) and social media accounts that could be relevant to investors. We encourage investors to follow us on Twitter and LinkedIn as well as to visit our website and/or subscribe to email alerts.

Contacts:

Investors
investors@kiorapharma.com

Media
kiora@crowepr.com
Crowe PR

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/204349

FAQ

When will Kiora Pharmaceuticals present at The 23rd Annual Needham Virtual Healthcare Conference?

Kiora Pharmaceuticals will present at The 23rd Annual Needham Virtual Healthcare Conference on April 11th at 10:15 am EDT.

What is the date and time of Kiora Pharmaceuticals' presentation at The Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference?

Kiora Pharmaceuticals will present at The Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference on April 18th at 2:30 pm EDT.

Where can investors access Kiora Pharmaceuticals' presentations?

Investors can access Kiora Pharmaceuticals' presentations live from the homepage of the investor relations section on Kiora's website (ir.kiorapharma.com) and replay them for 90 days on the investor relations 'events' page.

Kiora Pharmaceuticals, Inc.

NASDAQ:KPRX

KPRX Rankings

KPRX Latest News

KPRX Stock Data

13.13M
2.97M
0.9%
49.25%
1.24%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
ENCINITAS